Here, we will review this question from the perspective of recent work using transgenic models designed to recapitulate a specific human cancer involving mutations affecting the tumour suppressor gene BRCA2, associated with hereditary predisposition to breast, ovarian, pancreatic and other cancers. The gene discussed is BRCA2; the disease is cancer.